All treatments
Treatment
GS-5245 tablets 175 mg clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingHuman Pharmacology (Phase I)- Other
A Phase 1 Open-label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics and Safety of Obeldesivir in Participants With Normal Renal Function and Renal Impairment
This study is looking at a new medicine called Obeldesivir for people with kidney problems. We want to see how the body handles the medicine and if it's safe. It's a very early study, focusing on how much medicine gets into the blood.
For: Renal ImpairmentGermany - Ongoing, recruitingPhase II and Phase III (Integrated)
A Phase 2/3 Single-Arm, Open-label Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Obeldesivir in Pediatric Participants With COVID-19
This study is looking at a new medicine called Obeldesivir for children with COVID-19. Researchers want to see if it's safe, how the body uses it, and if it helps children recover. They are testing two different dose strengths.
For: COVID-19Poland · Spain · Italy